- Report
- January 2026
- 194 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 192 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 184 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 185 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 191 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- January 2026
- 197 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
- 185 Pages
Global
From €3187EUR$3,545USD£2,766GBP
€3541EUR$3,939USD£3,073GBP
- Report
- August 2025
Global
From €4404EUR$4,900USD£3,823GBP
- Report
- March 2026
- 267 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 287 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 582 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 182 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 180 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 282 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 243 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 288 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 287 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 377 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 383 Pages
Global
From €5258EUR$5,850USD£4,565GBP
- Report
- March 2026
- 390 Pages
Global
From €5258EUR$5,850USD£4,565GBP

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body.
PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more